MyRocky vs Hers Canada (2026): GLP-1 Weight Loss for Women

Canadian women seeking GLP-1 weight management online face a distinctive version of the platform selection problem. The clinical literature is clear that GLP-1 medications work across sexes, but the surrounding context of weight management - hormonal influences on appetite and metabolism, interactions with contraception, the specific role of weight in conditions like PCOS and perimenopause - is meaningfully different for women. Two platforms have staked out distinct positions on how to address that complexity.

Hers is the women-focused counterpart to the Hims brand and explicitly markets itself as a women's health platform. It offers GLP-1 prescriptions alongside birth control, hair loss treatment, skincare, and mental health support. The proposition is a single platform for multiple health needs, with weight management as one component of a broader wellness ecosystem.

MyRocky is not gender-specific by positioning, but serves women equally and approaches GLP-1 weight management with clinical depth that applies across patient demographics. Its lab-inclusive intake, structured titration program, and 6-month money-back guarantee are features that matter regardless of sex - but that have particular relevance for women who may have complex health histories involving hormonal medications or metabolic conditions.

This comparison evaluates both platforms specifically from the perspective of Canadian women choosing a GLP-1 program.

Platform Overview

Clinical Approach for Women

GLP-1 medications affect appetite, gastric emptying, and metabolic signalling - all of which can interact with hormonal contraception, thyroid function, and conditions like polycystic ovary syndrome (PCOS) that are common in women seeking weight management support. The clinical intake process for a GLP-1 program should ideally capture this context.

MyRocky's intake includes a lab-based assessment that establishes baseline metabolic parameters. While its primary focus is not women's health as a category, the clinical intake process is thorough enough to surface contraindications and relevant comorbidities including thyroid conditions. The in-house clinical team then monitors the patient across the titration program with regular check-ins, adjusting the protocol as needed.

Hers approaches the same intake from a women's health platform perspective. The questionnaire is attentive to hormonal and reproductive health history, and the broader platform context means practitioners are accustomed to thinking about GLP-1 treatment alongside contraception, hormonal health, and related conditions. For women who are simultaneously managing several health conditions and want one platform that understands the interactions between them, this framing is genuinely valuable.

However, Hers's GLP-1 offering is nested within a lifestyle and wellness product framework. The depth of clinical oversight for the GLP-1 program specifically is less formalised than MyRocky's structured titration protocol. Women who primarily want rigorous metabolic management rather than holistic wellness support may find MyRocky's specialist approach more aligned with their goals.

Pricing Breakdown

Both platforms use subscription-style pricing, but the structure and transparency differ. MyRocky publishes its fees openly: a $99 initial consultation and a monthly program fee that covers clinical support and medication. Hers discloses its pricing after you complete the health intake - a common DTC practice that allows the platform to customise pricing based on indicated dose, but which makes advance comparison harder.

For women using Hers exclusively for GLP-1, the monthly pricing is broadly comparable to MyRocky - the gap is in structure and transparency rather than base cost. The picture changes if a woman adds other Hers health services: costs accumulate across categories, though the per-service pricing may still be competitive with sourcing those services separately.

Province Coverage

Province coverage is where the two platforms diverge most sharply. MyRocky is available in all 10 provinces. Hers Canada excludes Quebec and New Brunswick - a gap that affects approximately 9 million Canadians, a significant proportion of whom are women who may otherwise be interested in the Hers platform's women-focused positioning.

Pharmacy and Dispensing

MyRocky dispenses through its own LegitScript-certified Mississauga pharmacy. Medications are prepared and shipped by a team that is part of the same organisation as the prescribing clinicians - meaning a question about a specific formulation, a dose adjustment, or a refill timing issue is handled within a single operational unit.

Hers Canada uses partner pharmacies for dispensing. The prescribing platform and the dispensing pharmacy are different entities, which introduces the coordination considerations common to any split model. For women who are also using Hers for hormonal contraception or other medications, this means multiple dispensing relationships may be needed - the platform does not consolidate all prescriptions through a single in-house pharmacy.

MyRocky's 6-Month Money-Back Guarantee

One of MyRocky's most distinctive features is its 6-month money-back guarantee. Patients who complete the program without achieving measurable weight loss are eligible for a refund under stated terms. For a category where outcomes are not uniform - a meaningful proportion of patients on GLP-1 medications achieve less than expected weight loss due to individual variation in drug response - the guarantee reduces the financial risk of starting a program.

Hers does not offer an equivalent guarantee on its GLP-1 program. Subscription terms are standard DTC subscription terms. This is not unusual for the category, but the comparison with MyRocky's explicit guarantee is worth noting for patients who are weighing the financial commitment against uncertainty about their individual response.

Pros and Cons

Verdict

The right answer here depends on what Canadian women prioritise in a health platform. The choice between these two is genuinely a trade-off between clinical specialisation and health ecosystem breadth.

For women who want the most rigorous GLP-1 program available - structured titration, lab-inclusive intake, in-house pharmacy, and a financial safety net in the form of a 6-month guarantee - MyRocky is the stronger choice. The fact that it serves all ten provinces, including Quebec and New Brunswick where Hers does not operate, makes it the accessible option by default for a significant population.

For women who want a single platform that manages multiple health needs - contraception, weight, skincare, mental health - and who are comfortable with a lifestyle-integrated rather than clinically regimented approach to GLP-1, Hers has genuine appeal. The ecosystem advantage is real: a practitioner who can see your full Hers health picture is better positioned to identify interactions between your medications than one who only sees your GLP-1 intake form.

If you are in Quebec or New Brunswick, or if rigorous clinical structure and cost predictability are your primary concerns, MyRocky is the more complete Canadian GLP-1 program. If ecosystem integration across multiple women's health categories matters more than GLP-1 program depth, and you are in a province where Hers operates, the platforms are closer to comparable.

Sponsored link above. WeightLossInjections.ca may earn a commission if you purchase through this link at no additional cost to you. Editorial assessments are independent. GLP-1 medications require a valid prescription from a licensed Canadian physician.